Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia Tim PreijersLisette M. SchütteRon A. A. Mathôt Review Article Open access 16 September 2020 Pages: 1 - 16
Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients Rachael LawsonChristine E. StaatzStefanie Hennig Review Article 30 October 2020 Pages: 17 - 51
Can Population Pharmacokinetics of Antibiotics be Extrapolated? Implications of External Evaluations Yu ChengChen-yu WangZheng Jiao Systematic Review 22 September 2020 Pages: 53 - 68
Influence of Cow’s Milk and Esomeprazole on the Absorption of Erlotinib: A Randomized, Crossover Pharmacokinetic Study in Lung Cancer Patients G. D. Marijn VeermanKoen G. A. M. HussaartsRon H. J. Mathijssen Original Research Article Open access 17 June 2020 Pages: 69 - 77
Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies Amit DesaiLauren BennerTong Zhu Original Research Article Open access 12 June 2020 Pages: 79 - 88
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing Anyue YinMadeleine H. T. EttaiebDirk Jan A. R. Moes Original Research Article Open access 30 June 2020 Pages: 89 - 102
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV Andrea CalcagnoJosé MoltóStefano Bonora Original Research Article 01 August 2020 Pages: 103 - 109
Simple Approach to Accurately Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies after Subcutaneous Injection in Humans Kenta HarayaTatsuhiko Tachibana Original Research Article 11 August 2020 Pages: 111 - 120
Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain Jitendra KanodiaArthur LoDavid L. Bourdet Original Research Article Open access 27 August 2020 Pages: 121 - 131
Drug–Drug Interaction Studies of Elagolix with Oral and Transdermal Low-Dose Hormonal Add-Back Therapy Ahmed NaderNael M. MostafaMohamad Shebley Original Research Article 21 July 2020 Pages: 133 - 143